REM's ultrasound
Type: Product
As of November 2026, REM's ultrasound has been mentioned in one podcast episode on The Diary Of A CEO (Oct 2025).
Radiofrequency Echographic Multi Spectrometry (REMS) is a non-ionizing technology for osteoporosis diagnosis and for fracture risk assessment. REMS processes the raw, unfiltered ultrasound signals acquired during an echographic scan of the axial sites, femur and spine. The analysis is performed in the frequency domain. Bone mineral density (BMD) is estimated by comparing the results against reference models.
| Mentioned in | 1 episode on 1 podcast (as of November 2026) |
|---|---|
| First heard | Oct 2025 on The Diary Of A CEO |
| Company | Various medical device manufacturers |
| Category | Physical good |
| Maker | Various medical device manufacturers |
Who talks about REM's ultrasound on podcasts?
REM's ultrasound came up; the most recent mention was Oct 2025 on The Diary Of A CEO.
What is REM's ultrasound mentioned alongside?
REM's ultrasound is most often mentioned alongside Meta Platforms, Inc., Muscle Protein Synthesis and North Carolina.
Mentioned together: Meta Platforms, Inc., Muscle Protein Synthesis, North Carolina, Adobe Express, Ketone IQ, Melatonin, Apple, avocado, magnesium, vitamin D